Association between sleep apnea syndrome and hypertension/endocrine disorders
Not Applicable
Recruiting
- Conditions
- sleep apnea syndrome, hypertension, metabolic syndrome
- Registration Number
- JPRN-UMIN000009301
- Lead Sponsor
- Keio university school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
patients with renal dysfunction (Cr>or=3.0)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood pressure after therapy for sleep apnea syndrome (nCPAP)
- Secondary Outcome Measures
Name Time Method Parameters for sleep disorders including AHI, parameters for metabolic disorders including BMI, plasma glucose, and continuous glucose monitoring, parameters for endocrine disorders including plasma/urinary aldosterone and catecholamines etc.